Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Progesterone Receptors. Found 15 abstracts

Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E. Breast cancer clinical characteristics and outcomes in Trinidad and Tobago. Journal of immigrant and minority health. 2015 Jun;17(3):765-72.
Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ. Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J. 2014 Jul;20(4):358-63.   PMCID: 4472437
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, Radice P, Ramus SJ, Domchek SM, Nathanson KL, Lee A, Healey S, Nussbaum RL, Rebbeck TR, Arun BK, James P, Karlan BY, Lester J, Cass I, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, v OH, Ejlertsen B, Gerdes AM, Nielsen FC, Dennis J, Cunningham J, Hart S, Slager S, Osorio A, Benitez J, Duran M, Weitzel JN, Tafur I, Hander M, Peterlongo P, Manoukian S, Peissel B, Roversi G, Scuvera G, Bonanni B, Mariani P, Volorio S, Dolcetti R, Varesco L, Papi L, Tibiletti MG, Giannini G, Fostira F, Konstantopoulou I, Garber J, Hamann U, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Douglas F, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Ong KR, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Eeles R, Davidson R, Hodgson S, Ellis S, Godwin AK, Rhiem K, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Steinemann D, Bogdanova-Markov N, Kast K, Varon-Mateeva R, Wang-Gohrke S, Gehrig A, Markiefka B, Buecher B, Lefol C, Stoppa-Lyonnet D, Rouleau E, Prieur F, Damiola F, Barjhoux L, Faivre L, Longy M, Sevenet N, Sinilnikova OM, Mazoyer S, Bonadona V, Caux-Moncoutier V, Isaacs C, Van Maerken T, Claes K, Piedmonte M, Andrews L, Hays J, Rodriguez GC, Caldes T, de la Hoya M, Khan S, Hogervorst FB, Aalfs CM, de Lange JL, Meijers-Heijboer HE, van der Hout AH, Wijnen JT, van Roozendaal KE, Mensenkamp AR, van den Ouweland AM, van Deurzen CH, van der Luijt RB, Olah E, Diez O, Lazaro C, Blanco I, Teule A, Menendez M, Jakubowska A, Lubinski J, Cybulski C, Gronwald J, Jaworska-Bieniek K, Durda K, Arason A, Maugard C, Soucy P, Montagna M, Agata S, Teixeira MR, Olswold C, Lindor N, Pankratz VS, Hallberg E, Wang X, Szabo CI, Vijai J, Jacobs L, Corines M, Lincoln A, Berger A, Fink-Retter A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea MK, Phelan CM, Mai PL, Greene MH, Rennert G, Imyanitov EN, Glendon G, Toland AE, Bojesen A, Pedersen IS, Jensen UB, Caligo MA, Friedman E, Berger R, Laitman Y, Rantala J, Arver B, Loman N, Borg A, Ehrencrona H, Olopade OI, Simard J, Easton DF, Chenevix-Trench G, Offit K, Couch FJ, Antoniou AC. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2014 Jan;16(6):3416.   PMCID: PMC4406179
Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast Cancer Res Treat. 2012 Jun;133(2):799-804.
Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clinical Cancer Research. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. Journal of Clinical Oncology. 2008 May 20;26(15):2473-81.
Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Molecular cancer research : MCR. 2007 Jan;5(1):71-85.
Jordan VC, Gelber RD. Problems with the progesterone receptor in practice?. J Clin Oncol. 2007 May 20;25(15):1957-9.
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70.
Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, Page R, Klein-Szanto AJ, Godwin AK, Liu J, Mills GB, Aldaz CM. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC cancer. 2005 Jan;5(1):64.
Russo J, Lareef H, Tahin Q, Russo IH. Pathways of carcinogenesis and prevention in the human breast. Eur J Cancer. 2002 Sep;38 Suppl 6:31-2.
Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dube MP, Kieback DG, Narod SA. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 2001 Oct;11(7):635-8.
Logginidou H, Ao X, Russo I, Henske EP. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest. 2000 Jan;117(1):25-30.
Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr. 2000 Jan;(27):17-37.
Henske EP, Ao X, Short MP, Greenberg R, Neumann HP, Kwiatkowski DJ, Russo I. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod Pathol. 1998 Jul;11(7):665-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Progesterone Receptors

Progesterone Receptors Female Estrogen Receptors Breast Neoplasms metabolism pathology Adult genetics Middle Aged Human therapeutic use BRCA1 Genes therapy BRCA2 Genes Genetic Predisposition to Disease Risk Factors Estrogens Ductal Carcinoma-Breast Middle Age physiology Immunoenzyme Techniques Aged erbB-2 Receptor Postmenopause Time Factors Carcinoma Alleles Kidney Neoplasms diagnosis drug therapy Lobular Carcinoma Mutation Angiomyolipoma Non-US Gov't Support Heterozygote ErbB-2 Receptor Neoplasm Staging Oral Contraceptives Epidermal Growth Factor Receptor Neoplastic Gene Expression Regulation US Gov't Support-PHS etiology Prospective Studies Treatment Outcome Hormone-Dependent Neoplasms pharmacology Lymphatic Metastasis Ovarian Neoplasms Cell Division 80 and over Aged Age Distribution Male Double-Blind Method Triple Negative Breast Neoplasms Comparative Study Nuclear Receptor Coactivator 2 1-Phosphatidylinositol 3-Kinase Lymph Nodes Estrogen Receptor alpha Retrospective Studies Quinazolines Cohort Studies Immunoblotting sentinel node biopsy Tamoxifen Multiple Primary Neoplasms GPI-Linked Proteins Prognosis Breast Cultured Tumor Cells Case-Control Studies Proto-Oncogene Proteins c-akt molecular subtype Triazoles T-Lymphocytes United States Gel Electrophoresis-Two-Dimensional immunology Antineoplastic Combined Chemotherapy Protocols Tumor Suppressor Genes Lung Neoplasms Antineoplastic Combined Chemotherapy Adjuvant Chemotherapy Ovary Estrogen Antagonists Genetic Models Genetic Transcription Nitriles Tumor Suppressor Proteins Germ-Line Mutation Neoplasm Antigens Age Factors anatomy & histology epidemiology Biopsy Western Blotting Immunotherapy receptor status Epithelial Cells Electrophoretic Mobility Shift Assay Questionnaires surgery Lymphangiomyomatosis Oxidoreductases Local Neoplasm Recurrence Presenilin-2 pharmacokinetics Oligonucleotide Array Sequence Analysis Biological Tumor Markers Disease-Free Survival secondary utilization Signal Transduction Mitogen-Activated Protein Kinase Kinases Carcinoma in Situ Genetic Transduction Australia Survival Rate administration & dosage Lymph Node Excision Tissue Distribution Immunohistochemistry Neoplasm Grading Gene Deletion Canada Delayed Diagnosis Logistic Models prevention & control Axilla breast cancer axillary lymph nodes DNA Replication deficiency Registries Tuberous Sclerosis Tumor Cell Line Protocols Loss of Heterozygosity Trinidad and Tobago Messenger RNA Response Elements Sentinel Lymph Node Biopsy growth & development Reverse Transcriptase Polymerase Chain Reaction Homozygote biosynthesis Cell Differentiation Promoter Regions (Genetics) Menopause drug effects
Last updated on Thursday, November 02, 2017